Research output
- 8 Article
-
Akute myeloische Leukämie - Neue Perspektiven in der diagnostischen und therapeutischen Landschaft
Popp, H., Dec 2023, In: Jatros Hämatologie und Onkologie. 1 p.Research output: Contribution to journal › Article › peer-review
-
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
Rotterdam, J., Thiaucourt, M., Weiss, C., Schwaab, J., Reiter, A., Kreil, S., Steiner, L., Fenchel, S., Popp, H. D., Hofmann, W.-K., Bonatz, K., Gerhards, C., Neumaier, M., Klein, S. A., Rao, S., Jawhar, M. & Saussele, S., Aug 2022, In: Annals of hematology. 101, 8, p. 1825-1834 10 p.Research output: Contribution to journal › Article › peer-review
-
Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells
Fabarius, A., Samra, V., Drews, O., Mörz, H., Bierbaum, M., Darwich, A., Weiss, C., Brendel, S., Kleiner, H., Seifarth, W., Greffrath, W., Hofmann, W.-K., Schmitt, C. A. & Popp, H. D., 11 Jun 2022, In: Cancers. 14, 12, 1 p., 2883.Research output: Contribution to journal › Article › peer-review
-
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
Naumann, N., Lübke, J., Baumann, S., Schwaab, J., Hoffmann, O., Kreil, S., Dangelo, V., Reiter, L., Bugert, P., Kristensen, T., Sotlar, K., Haselmann, V., Schneider, S., Metzgeroth, G., Weiss, C., Popp, H. D., Fabarius, A., Hofmann, W.-K., Cross, N. C. P. & Reiter, A. & 1 others, , 04 Mar 2021, In: International Journal of Molecular Sciences. 22, 5, p. 1-12 12 p., 2562.Research output: Contribution to journal › Article › peer-review
-
Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10-100 kDa Fraction of Conditioned Medium
Kohl, V., Fabarius, A., Drews, O., Bierbaum, M., Jawhar, A., Darwich, A., Weiss, C., Flach, J., Brendel, S., Kleiner, H., Seifarth, W., Hofmann, W.-K. & Popp, H. D., 07 Apr 2021, In: Cells. 10, 4, 827.Research output: Contribution to journal › Article › peer-review
-
ABCSG61 Teodor
Stegemann, M. (Researcher), Kausche, L. E. (Researcher), Lichtenauer, N. (Researcher), Popp, H. D. (Researcher), Schwarz, H. K. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Ghanem, R. (Researcher), Schmitt, C. (Researcher), Preuß, C. (Researcher), Piringer, G. (Researcher), Stefan, A. (Researcher) & Kovacsova, J. (Researcher)
03.03.2026 → 02.09.2028
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (ARGX-113-2402)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
04.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
Phase III randomized, open-label, international, multicenter study evaluating the efficacy and safety of mosunetuzumab plus lenalidomide in comparison to anti- CD20 monoclonal antibody plus chemotherapy in subjects with previously untreated FLIPI 2-5 follicular lymphoma (MorningLyte)
Schmitt, C. (PI), Krivic, D. (Researcher), Lichtenauer, N. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
02.06.2025 → 31.05.2029
Project: Clinical studies › Clinical Study (Industry project)
-
AGMT Metastasic Colorectal Cancer Registry (mCRC) Third Line and Beyond (mCRC Registry)
Krivic, D. (Researcher), Piringer, G. (PI), Lichtenauer, N. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Schwarz, H. K. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher) & Trathnigg, N. (Researcher)
20.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
-
A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery (MK-2870-012)
Krivic, D. (Researcher), Preuß, C. I. (PI), Schwarz, H. K. (Researcher), Schmitt, C. (Researcher), Kühr, T. (Researcher), Schneeweiß, B. (Researcher), Piringer, G. (Researcher), Popp, H. D. (Researcher), Krenosz, K. J. (Researcher), Ghanem, R. (Researcher), Stefan, A. (Researcher), Kovacsova, J. (Researcher), Kausche, L. E. (Researcher), Stegemann, M. (Researcher), Klein, K. (Researcher), Trathnigg, N. (Researcher) & Lichtenauer, N. (Researcher)
18.12.2024 → 31.12.2029
Project: Clinical studies › Clinical Study (Industry project)
Activities
- 1 Contributed talk
-
Akute myeloische Leukämie - Klinisch relevante aktuelle Studiendaten
Popp, H. D. (Speaker)
04 Oct 2023Activity: Talk or presentation › Contributed talk › science-to-science